Inhalation of nitric oxide as a life-saving therapy in a patient after pulmonary embolectomy

British Journal of Anaesthesia

Volumn 82, Issue 3, 1999, Pages 444-447

  Schenk, P ^a   Pernerstorfer, T ^a   Mittermayer, C ^a   Kranz, A ^a   Frommel M ^c   Birsan, T ^b   Ratheiser, K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

Author keywords

Complications, pulmonary hypertension; Embolus, embolism; Pharmacology, nitric oxide

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; BREATHING; CARDIOGENIC SHOCK; CASE REPORT; EMBOLECTOMY; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; LUNG EMBOLISM; MALE; PRIORITY JOURNAL;

EID: 0033029581     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/82.3.444     Document Type: Article

References (16)

1. Moncada S, Higgs A. The L-arginine nitric oxide pathway. N Engl J Med 1993; 329: 2002-12
2. Rossaint R, Falke JK, Lopez F, Slama K, Pison U, Zapol W. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405
3. Sellden H, Winberg P, Gustafsson LE, Lundell B, Book K, Frostell C. Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2 kg infant. Anesthesiology 1993; 78: 413-16
4. Girard C, Lehot J, Pannetier J, Filley IS, French P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary hypertension. Anaesthesiology 1992; 77: 880-3
5. Mertes PM, Pinelli G, Hubert T, et al. Impact of nitric oxide inhalation on right ventricular failure after implantation of Novacor left ventricular assist system. J Thorac Cardiovasc Surg 1995; 109: 1251
6. Girard C, Durand PG, Vedrinne C, et al. Inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vasc Anesth 1993; 7: 481-5
7. Sitbon O, Brenot F, Denjean A, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. Am J Respir Crit Care Med 1995; 151: 384-9
8. Burghuber OC. Doppler assessment of pulmonary haemodynamics in chronic hypoxic lung disease. Thorax 1996; 51: 9-12
9. Manny J, Hechtman HB. Vasoactive humoral factors. In: Goldhaber SZ, ed. Pulmonary Embolism and Deep Venous Thrombosis. Philadelphia: WB Saunders, 1985; 283
10. Smith WJ, Murphy MP, Appleyard RF, et al. Prevention of complement-induced pulmonary hypertension and improvement of right ventricular function by selective thromboxane receptor antagonism. J Thorac Cardiovasc Surg 1994; 107: 800-6
11. Morita K, Ihnken K, Buckberg GD, Sherman MP, Ignarro LJ. Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass. Ann Thorac Surg 1996; 61: 1775-80
12. Estagnasié P, Le Bourdellès G, Mier L, Coste F, Dreyfuss D. Use of inhaled nitric oxide to reverse flow through a patent foramen ovale during pulmonary embolism. Ann Intern Med 1994; 120: 757-9
13. Capellier G, Jacques T, Balvay P, Blasco E, Belle E, Barale F. Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med 1997; 23: 1089-92
14. Huval WV, Mathieson MA, Stemp LI, et al. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism. Ann Surg 1983; 197: 220-5
15. Samama CM, Diaby M, Fellahi JL, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1995; 83: 56-65
16. Gries A, Böttiger BW, Dörsam J, et al. Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigs. Anesthesiology 1997; 86: 387-93